催化学报  2018, Vol. 39 Issue (9): 1463-1469   PDF    
扩展功能
加入收藏夹
复制引文信息
加入引用管理器
Email Alert
RSS
本文作者相关文章
Wenfang Wang
Qiangsheng Sun
Chungu Xia
Wei Sun
Enantioselective epoxidation of olefins with hydrogen peroxide catalyzed by bioinspired aminopyridine manganese complexes derived from L-proline
Wenfang Wanga,b, Qiangsheng Suna, Chungu Xiaa, Wei Suna     
a. State Key Laboratory for Oxo Synthesis and Selective Oxidation, Lanzhou Institute of Chemical Physics, Chinese Academy of Sciences, Lanzhou 730000, Gansu, China;
b. University of Chinese Academy of Sciences, Beijing 100049, China
* Corresponding author. Wei Sun, Tel: +86-931-4968278; Fax: +86-931-4968129; E-mail: wsun@licp.cas.cn
Foundation item: This work was supported by the National Natural Science Foundation of China (21473226, 21773273), Key Research Program of Frontier Sciences, CAS (QYZDJ-SSW-SLH051), and Natural Science Foundation of Jiangsu Province (BK20170420)
Abstract: Three chiral aminopyridine ligands derived from L-proline were prepared. Careful evaluation of the corresponding aminopyridine manganese complexes in asymmetric epoxidation of olefins revealed a broad substrate scope in the presence of 0.2 mol% manganese complex and 0.5 equiv. 2, 2-dimethylbutyric acid, with aqueous hydrogen peroxide as an oxidant. A variety of olefins including styrenes, chromenes, and cinnamamides were transformed successfully into the target epoxides with moderate to excellent enantioselectivity (yield up to 95%, ee up to 99%).
© 2018, Dalian Institute of Chemical Physics, Chinese Academy of Sciences.
Published by Elsevier B.V. All rights reserved.
Key words: Aminopyridine ligand    Manganese    Asymmetric epoxidation    Hydrogen peroxide    Olefin    
脯氨酸衍生的胺基吡啶四氮锰配合物催化双氧水参与的烯烃不对称环氧化反应
王文芳a,b, 孙强盛a, 夏春谷a, 孙伟a     
a. 中国科学院兰州化学物理研究所羰基合成与选择氧化国家重点实验室, 甘肃兰州 730000;
b. 中国科学院大学, 北京 100049
摘要:自然界中存在许多的金属酶,它们参与促进各种各样的氧化反应,例如羟化反应,环氧化反应等.金属酶催化的反应具有催化效率高、反应条件温和、选择性高等优点.受大自然中的金属酶结构及其性质的启发,人们提出了仿生催化氧化的理念,并开始对金属酶进行模拟,致力于发展清洁氧化的反应方式.在过去的几十年中,科学家们设计合成了一系列仿生金属配合物催化剂.例如,利用非手性的乙二胺骨架设计合成出四齿氮配体MEP(NN'-dimethyl-NN'-bis(2-pyridinylmethyl)ethane-1,2-diamine),将其制备成相应的铁配合物催化剂,该铁催化剂可以很好的实现脂肪族烯烃的环氧化,产率高达90%.2003年,Stack小组首次报道了利用手性NN-二甲基环己二胺骨架衍生的四齿氮配体金属配合物Mn-MCP-(OTf)2(MCP=NN-dimethyl-NN-bis(2-pyridylmethyl)cyclohexane-trans-1,2-diamine)催化的不对称环氧化反应.该反应的对映选择性仅仅为10%.因此,发展新型手性四氮配体金属配合物,用于高产率、高对映选择性的不对称环氧化反应,值得进行深入研究. 近年来发展的一些含手性二胺骨架的四齿氮配体,例如PDP(2-[[2-(1-(pyridin-2-ylmethyl)-pyrrolidin-2-yl)pyrrolidin-1-yl]methyl]pyridine),被应用到不对称环氧化反应中,但是其手性二胺骨架为联吡咯,价格昂贵,难以制备.这在很大程度上限制了其在不对称合成中的实际应用.因此,利用一些易于合成的手性二胺骨架,发展结构新颖、催化性能优良的四氮金属配合物,成为实现高效、高选择性不对称环氧化反应的关键. 在之前的工作基础上,本文以简单易得、价格低廉的天然氨基酸——L-脯氨酸为起始原料,选取吡啶环和含取代基的吡啶环作为侧基氮供体,制备了三种手性四齿氮配体.随后,我们利用新发展的手性四齿氮配体,合成了相应的锰配合物,并且分别将其运用于烯烃不对称环氧化反应中,仔细评估了这些锰金属配合物的催化性能.建立了以0.2mol%的锰配合物为催化剂,0.5当量的2,2-二甲基丁酸为添加剂,30%双氧水为氧化剂,反应温度为–30℃,乙腈为溶剂的催化不对称环氧化反应体系.反应结果显示:该催化剂催化的不对称环氧化反应底物适用性广泛,其中苯乙烯、苯并吡喃、烯酰胺等化合物均可以被成功地转化为相应的环氧化物,得到中等至优异的对映选择性(产率最高可达95%,对映选择性最高可达99%).
关键词胺基吡啶配体        不对称环氧化    双氧水    烯烃    

1 Introduction

Metalloenzymes can promote a wide range of oxidative transformations, such as hydroxylation, epoxidation, and cis-dihydroxylation. Inspired by the properties of metalloenzymes, researchers have established biomimetic synthetic metal (e.g., Mn, Fe) complexes coordinated with tetradentate nitrogen (N4) ligands as excellent catalysts in oxidation reactions in the past decades [1-4]. The landmark investigations of epoxidation of olefins by biomimetic N4 metal complexes were begun in 2001 by Jacobsen and co-workers [5]. They reported that an Fe(Ⅱ)(mep) complex (mep = N, N′-dimethyl-N, N′-bis (2-pyridinylmethyl)ethane-1, 2-diamine) could rapidly mediate the epoxidation of aliphatic alkenes with aqueous hydrogen peroxide as the oxidant; note that acetic acid served as an important additive in the iron catalytic system. Earlier in the same year, Que and co-workers [6] first demonstrated enantioselective cis-dihydroxylation of olefins catalyzed by the iron complex of the aminopyridine N4 ligand. In 2003, Mn-MCP-(OTf)2 [MCP = N, N-dimethyl-N, N-bis(2-pyridylmethyl) cyclohexane-trans-1, 2-diamine] was used in the epoxidation of olefins with peracetic acid as an oxidant by Stack and co-workers; importantly, an ee of 10% was observed in the epoxidation of vinyl cyclohexane [7]. The development of novel elegant ligands is considered the key approach to obtaining highly efficient catalysts [8, 9]. In this context, Costas [10-14], Talsi and Bryliakov [15-20], Gao [21, 22], and our group [23-31] have developed many chiral N4 ligands, and their manganese and iron complexes exhibit good to excellent stereocontrol in the enantioselective epoxidation of various olefins (Scheme 1). Among them, the chiral N4 ligands derived from chiral 2, 2′-bipyrrolidine play an important role in iron- or manganese-catalyzed asymmetric epoxidation of olefins (Scheme 1)[11, 12, 14, 16-20]. However, these chiral 2, 2′-bipyrrolidine skeletons are not easily available and are costly. In addition, the epoxidation catalyzed by manganese or iron complexes coordinated by these documented ligands requires a large quantity of acids as a vital additive [16, 23]. It has been proposed that protonation of the hydroperoxide ligand by the coordinated carboxylic acid in metal-hydroperoxo intermediates facilitates O–O bond cleavage, generating high-valent metal-oxo species as reactive epoxidizing intermediates. Recently, Costas and co-workers reported that the quantity of carboxylic acid could be dramatically decreased to catalytic loading by including dimethylamino groups at the 4-position of the PDP ligand [Scheme 1, NMe2PDP, PDP = 2-({2-[1-(pyridin-2-ylmethyl)-pyrrolidin-2-yl]pyrrolidin-1-yl}methyl) pyridine] [12, 13]. In 2012, we reported a series of facile N4 ligands (Scheme 1, S-PMP, S-PEB) derived from L-proline, which exhibited enantioselectivity comparable to those of chiral 2, 2′-bipyrrolidine skeletons [28-32]. More importantly, L-proline is abundant in nature and easily transformed and diversified.

Scheme 1. Tetradentate nitrogen (N4) ligands.

On the basis of our previous work, we hypothesized that modification of the substituents on the pyridyl groups and diamine backbone of the N4 ligand from L-proline would provide several new and practical N4 ligands. Herein, we report three structurally new aminopyridine ligands derived from L-proline and the catalytic performance of the corresponding manganese complexes in asymmetric epoxidation of a variety of olefins using aqueous hydrogen peroxide as an oxidant.

2 Experimental
2.1 General

The starting materials were purchased from commercial suppliers and used without further purification. 1H NMR and 13C NMR spectra were recorded on a Bruker Avance Ⅲ 400 MHz spectrometer using CDCl3 as the solvent with tetramethylsilane as an internal reference. Gas chromatography–mass spectrometry (GC–MS) spectra were recorded on an Agilent Technologies 7890A GC system with an Agilent 5975 inert mass-selective detector (EI) and an HP-5MS column (0.25 mm × 30 m, film: 0.25 μm). High-performance liquid chromatography (HPLC) analysis was performed on a Waters-Breeze instrument (2487 Dual λ absorbance detector and 1525 binary HPLC pump). Chiralpak OD-H, AS-H, and IC columns were purchased from Daicel Chemical Industries, Ltd. GC analysis was performed on an Agilent 6820 GC instrument with a CP-Chirasil-Dex CB column. Column chromatography was generally performed on silica gel (300–400 mesh), and thin-layer chromatography inspections were performed on silica gel GF254 plates.

L-proline-based diamines 1 and 2 were synthesized using a previously reported method [28, 29, 33].

2.2 Synthesis and characterization of ligands L1L3

For L1, (S)-N-methyl-1-(pyrrolidin-2-yl)methanamine (1) (2.1 mmol) and 30 mL of dichloromethane (DCM) were added to a 100-mL round-bottom flask. Then K2CO3 (6 eq.) was added. Next, 2-(chloromethyl)-N, N-dimethylpyridin-4-amine (3) (5.0 mmol) was dissolved in 20 mL of DCM by addition through a constant-pressure dropping funnel at 0 ℃. Then the mixture was stirred in an ice bath for 1 h and gradually warmed to room temperature overnight. The mixture was then filtered, and the filter was washed with DCM. The combined filtrates were evaporated under reduced pressure. To the resulting residue, a solution of NaOH (2 mol/L) was added to adjust the pH to greater than 10, and the mixture was extracted with 3 × 20 mL of DCM. The combined organic phases were washed successively with saturated aqueous solutions of NaCl and H2O. The organic phase was dried over anhydrous Na2SO4, and the solvent was removed under reduced pressure. The residue was purified by a silica column to yield the ligand L1 (330 mg, 41%). 1H NMR (400 MHz, CDCl3) δ 8.10–7.94 (m, 2H), 6.60 (d, J = 8.0 Hz, 2H), 6.31 (dd, J = 8.0, 4.0 Hz, 2H), 4.17 (d, J = 12.0 Hz, 1H), 3.50 (dt, J = 28.0, 16.0 Hz, 3H), 2.89 (dd, J = 12.0, 4.0 Hz, 12H), 2.82 (t, J = 8.0 Hz, 2H), 2.58–2.47 (m, 1H), 2.39–2.25 (m, 2H), 2.21 (s, 3H), 2.02–1.87 (m, 1H), 1.7–1.51 (m, 3H). 13C NMR (101 MHz, CDCl3) δ 158.2, 157.9, 155.2, 155.1, 147.6, 147.5, 105.8, 105.4, 105.3, 105.2, 64.1, 62.5, 62.2, 60.9, 54.7, 43.2, 39.2, 39.1, 29.8, 23.0. High-resolution MS (HRMS) [electrospray ionization (ESI) MS] calcd. for C22H35N6 [M+H]+: 383.2918, found: 383.2924.

L2 was prepared using a method analogous to that used for L1 starting with (S)-N-benzyl-1-(pyrrolidin-2-yl) methanamine (2) (2.1 mmol) and 2-(chloromethyl)-N, N-dimethylpyridin-4-amine (6) (5.0 mmol) to provide a yellow oil (356 mg, 37%). 1H NMR (400 MHz, CDCl3) δ 7.62 (t, J = 4.0 Hz, 4H), 7.43–7.12 (m, 5H), 6.41 (d, J = 2.0 Hz, 1H), 6.34 (dd, J = 8.0, 4.0 Hz, 1H), 4.33 (d, J = 8.0 Hz, 1H), 4.24–4.01 (m, 2H), 3.66–3.50 (m, 3H), 2.99 (s, 12H), 2.81 (dd, J = 12.0, 4.0 Hz, 2H), 2.67 (dd, J = 12.0, 8.0 Hz, 1H), 2.37 (dd, J = 12.0, 8.0 Hz, 1H), 2.05–1.80 (m, 2H), 1.76–1.60 (m, 3H), 1.61–1.42 (m, 1H). 13C NMR (101 MHz, CDCl3) δ 156.1, 155.3, 143.2, 132.1, 130.2, 128.8, 105.2, 104.7, 61.4, 59.1, 54.4, 53.5, 51.7, 51.3, 39.7, 29.1, 23.9. HRMS (ESI-MS) calcd. for C28H39N6 [M+H]+: 459.3231, found: 459.3218.

L3 was prepared using a method analogous to that used for L1 starting with (S)-N-methyl-1-(pyrrolidin-2-yl) methanamine (1) (2.1 mmol) and 2-(chloromethyl)- 4-methoxy-3, 5-dimethylpyridine (4) (5.0 mmol) to yield the ligand L3 (398 mg, 46%). 1H NMR (400 MHz, CDCl3) δ 8.07 (s, 2H), 4.04 (d, J = 12.0 Hz, 1H), 3.65 (d, J = 8.0 Hz, 6H), 3.46 (dd, J = 44.0, 12.0 Hz, 3H), 2.76 (s, 1H), 2.59 (s, 1H), 2.36 (dd, J = 12.0, 4.0 Hz, 2H), 2.23 (s, 3H), 2.19 (s, 4H), 2.14 (s, 5H), 2.11 (s, 3H), 2.03–1.78 (m, 2H), 1.63–1.49 (m, 2H), 1.48–1.37 (m, 1H). 13C NMR (101 MHz, CDCl3) δ 164.0, 163.8, 157.0, 148.3, 148.2, 126.1, 125.5, 125.0, 124.8, 63.6, 62.6, 59.9, 59.8, 59.7, 54.9, 43.1, 30.2, 22.6, 13.2, 10.9. HRMS (ESI-MS) calcd. for C24H37N4O2 [M+H]+: 413.2911, found: 413.2905.

2.3 Synthesis and characterization of the manganese complexes C1C3

C1: Mn(CF3SO3)2 (0.25 mmol, 1 eq.) was added to a stirred solution of chiral ligand L1 (0.25 mmol, 1 eq.) in acetonitrile (3 mL) at room temperature. The reaction mixture was stirred for 24 h. After drying under vacuum, the resulting solid was washed thoroughly with ether three times. It was then dried under vacuum to yield C1 (yield, > 90%). HRMS (ESI-MS) calcd. for C23H34F3MnN6O3S [M-OTf]+: 586.1740, found: 586.1763.

C2 was prepared using a method analogous to that used for C1 starting with L2 and Mn(CF3SO3)2 to obtain the product as a solid (yield, > 90%). HRMS (ESI-MS) calcd. for C29H38F3MnN6O3S [M-OTf]+: 662.2058, found: 662.2070.

C3 was prepared using a method analogous to that used for C1 starting with L3 and Mn(CF3SO3)2 to obtain the product as a solid (yield, > 90%). HRMS (ESI-MS) calcd. for C24H36MnN4O2 [M-2OTf]2+: 233.6104, found: 233.6096.

2.4 General procedures for asymmetric epoxidation

In a typical reaction, a MeCN (0.5 mL) solution consisting of the substrate (0.4 mmol), catalyst (0.2 mol%), and acid (0.5 eq.) was mixed in a 10-mL flask at −30 ℃. Then a H2O2 solution (1.5 eq., diluted from a 30% aqueous solution in 0.5 mL of MeCN) was added via a syringe pump over 30 min with stirring at −30 ℃. The solution was further stirred at –30 ℃ for 30 min. At this point, decane was added to the mixture as an internal reference. The reaction was quenched with saturated NaHCO3 aqueous solution and saturated Na2S2O3 aqueous solution and extracted with DCM; the sample was then investigated using GC and GC–MS analysis or purified by chromatography on silica gel to afford the epoxide product.

3 Results and discussion

The structure of a ligand is known to have an important effect on the activity of metal complex catalysts. In 2013, Costas and coworkers [12, 34] reported that the electronic properties of a metal center could be tuned by introducing different substituents on the pyridine ring at the 4-position. In particular, a metal complex bearing dimethylamino groups on the ligand framework exhibited excellent activity (Scheme 1, Me2NPDP ligand). Further, Que and coworkers [35] captured a key oxoiron(Ⅴ) intermediate with a 50% yield, which was considered to be the active species in the oxidation reaction and was hard to synthesize and characterize, by introducing 4-methoxy-3, 5-dimethylpyridine (dMM-pyridine) instead of pyridine donors into the tris(pyridine-2-ylmethyl)amine ligand. Recently, Wang and coworkers [36] also demonstrated, using density functional theory calculations, that an Fe(Ⅳ)-oxo cation radical species was generated when dimethylamino groups were introduced into PDP-Fe complex catalysts. These results indicated that using different substituents on ligands did change the spin state of the metal center and the activity of these metal complexes. Thus, we tried to synthesize three different tetradentate nitrogen ligands bearing strong electron-donating substituents (the Me2N or dMM group) and the corresponding manganese complexes.

The aminopyridine ligands L1L3 derived from L-proline were readily prepared, as shown in Scheme 2, and the manganese complexes were synthesized using the modified N4 ligands L1L3 with Mn(OTf)2 and stirring in CH3CN at room temperature for 24 h.

Scheme 2. Preparation of tetradentate nitrogen ligands derived from L-proline.

The activities of three structurally new catalysts were then examined in asymmetric epoxidation. We selected cis-β-methylstyrene as a model substrate and used 2, 2-dimethylbutanoic acid (DMBA) as the additive [26]. Epoxidation was performed in CH3CN at –30 ℃ using 30% aqueous H2O2 (1.5 eq.) as the oxidant. It was shown that the catalyst C1 (0.1 mol%) was the most effective, furnishing epoxide in 84% yield and 82% ee (Table 1, entry 1). Surprisingly, the manganese catalyst C2, with a larger steric hindrance, exhibited decreased performance despite its richer electronic properties (Table 1, entry 2). In addition, the manganese complex C3, with fewer electron-donating dMM groups, exhibited lower yield and enantioselectivity under the same conditions (Table 1, entry 3). To improve the conversion in epoxidation, a larger catalyst loading (0.2 mol%) was tested, and it was found that the substrate converted completely, and a 92% yield and 88% ee were obtained (Table 1, entry 4). The reaction proceeded well even in the presence of 50 mol% DMBA when 0.2 mol% manganese complex C1 was used (Table 1, entry 5).

Table 1
Reaction condition screening.

In addition, the carboxylic acids also played an important role in the non-heme-metal-complex-promoted epoxidation by H2O2 because these reactions were achieved by the proposed "carboxylic-acid-assisted" O–O bond cleavage mechanism (Scheme 3) [16]. In 2016, Talsi and coworkers [20] studied the effect of carboxylic acids on the electronic structure of the intermediates in asymmetric epoxidation. They found that these acids with tertiary α-carbon atoms displayed a smaller g-factor anisotropy, which resulted in higher enantioselectivities [20]. Very recently, we demonstrated that only the carboxylic acid binding on the manganese center can activate H2O2 to produce a presumed carboxylic MnV=O (Ⅱ) as the oxidizing reagent (Scheme 3). Thus, the carboxylic ligand coordinated on the manganese center could affect the stereocontrol of the asymmetric epoxidation [37]. In this context, we then evaluated the contribution of different carboxylic acids to this process. The results showed that DMBA was the best additive, giving a 90% yield and 89% ee (Table 1, entry 5). Other acids, such as D-camphoric acid (D-CPA), acetic acid, 4-methylhexanoic acid (4-MHA), pivalic acid (PVA), and 2-ethylhexanoic acid (EHA), resulted in lower ee values (Table 1, entries 6–10). Further lowering the acid loading degraded the performance (Table 1, entries 11 and 12).

Scheme 3. Proposed mechanism of catalysis by tetradentate manganese complexes assisted by carboxylic acid.

After establishing the optimized conditions using the manganese complex C1, we investigated the generality of the reaction of different olefins. First, various styrenes were examined under the optimal conditions. Gratifyingly, styrenes bearing different substituents were transformed to epoxides successfully, albeit with moderate enantioselectivities (Table 2, entries 1–7). In addition, the epoxidation of stilbene compounds provided epoxides in low yield, but the enantioselectivity was quite good (Table 2, entries 6 and 7). To our delight, chromenes (Table 2, entries 8 and 9) and cinnamamides (Table 2, entries 10–15) were well-tolerated, and the target products were assembled with excellent enantioselectivities (up to 99% ee).

Table 2
Substrate scope of olefins.
4 Conclusions

In conclusion, we developed a series of novel tetradentate nitrogen ligands derived from L-proline. The corresponding manganese complexes were then prepared, and their catalytic activities and selectivities were evaluated in asymmetric epoxidation of olefins. Various olefins were transformed into epoxides successfully with low loading of the manganese catalyst together with aqueous H2O2 as the oxidant in the presence of a small amount of carboxylic acid as an additive. Notably, the enantioselective epoxidation of chromenes and cinnamamides provided the target products with excellent enantioselectivities (up to 99% ee). Unlike the substituted PDP ligands, these N4 ligands were prepared from readily available and inexpensive amino acids, thus making the manganese catalysts more practical. Further utilization of these biomimetic manganese complexes in oxidation reactions is ongoing in our laboratory.

Acknowledgments

Technical assistance, material support, and other help or advice may be acknowledged briefly in this section (excluding financial support, which should appear in the footnote on the title page).

References
[1]
E. P. Talsi, K. P. Bryliakov, Coord. Chem. Rev., 2012, 256: 1418-1434. DOI:10.1016/j.ccr.2012.04.005
[2]
K. P. Bryliakov, E. P. Talsi, Coord. Chem. Rev., 2014, 276: 73-96. DOI:10.1016/j.ccr.2014.06.009
[3]
O. Cusso, X. Ribas, M. Costas, Chem. Commun., 2015, 51: 14285-14298. DOI:10.1039/C5CC05576H
[4]
C. X. Miao, C. G. Xia, W. Sun, Sci. Sin. Chim., 2014, 44: 1865-1875. DOI:10.1360/N032014-00199
[5]
M. C. White, A. G. Doyle, E. N. Jacobsen, J. Am. Chem. Soc., 2001, 123: 7194-7195. DOI:10.1021/ja015884g
[6]
M. Costas, A. K. Tipton, K. Chen, D. H. Jo, L. Que Jr, J. Am. Chem. Soc., 2001, 123: 6722-6723. DOI:10.1021/ja015601k
[7]
A. Murphy, G. Dubois, T. D. P. Stack, J. Am. Chem. Soc., 2003, 125: 5250-5251. DOI:10.1021/ja029962r
[8]
K. Chen, H. Xie, Chin. J. Catal., 2017, 38: 625-635. DOI:10.1016/S1872-2067(17)62777-3
[9]
J. Q. Zhang, Y. S. Peng, W. G. Leng, Y. A. Gao, F. F. Xu, J. L. Chai, Chin. J. Catal., 2016, 37: 468-475. DOI:10.1016/S1872-2067(15)61050-6
[10]
L. Gómez, I. Garcia-Bosch, A. Company, X. Sala, X. Fontrodona, X. Ribas, M. Costas, Dalton Trans., 2007, 5539-5545.
[11]
O. Cussó, M. Cianfanelli, X. Ribas, R. J. M. K. Gebbink, M. Costas, J. Am. Chem. Soc., 2016, 138: 2732-2738. DOI:10.1021/jacs.5b12681
[12]
O. Cussó, I. Garcia-Bosch, X. Ribas, J. Lloret-Fillol, M. Costas, J. Am. Chem. Soc., 2013, 135: 14871-14878. DOI:10.1021/ja4078446
[13]
O. Cussó, I. Garcia-Bosch, D. Font, X. Ribas, J. Lloret-Fillol, M. Costas, Org. Lett., 2013, 15: 6158-6161. DOI:10.1021/ol403018x
[14]
I. Garcia-Bosch, L. Gómez, A. Polo, X. Ribas, M. Costas, Adv. Synth. Catal., 2012, 354: 65-70. DOI:10.1002/adsc.201100409
[15]
R. V. Ottenbacher, K. P. Bryliakov, E. P. Talsi, Adv. Synth. Catal., 2011, 353: 885-889. DOI:10.1002/adsc.v353.6
[16]
O. Y. Lyakin, R. V. Ottenbacher, K. P. Bryliakov, E. P. Talsi, ACS Catal., 2012, 2: 1196-1202. DOI:10.1021/cs300205n
[17]
R. V. Ottenbacher, D. G. Samsonenko, E. P. Talsi, K. P. Bryliakov, ACS Catal., 2014, 4: 1599-1606. DOI:10.1021/cs500333c
[18]
R. V. Ottenbacher, E. P. Talsi, K. P. Bryliakov, ACS Catal., 2015, 5: 39-44. DOI:10.1021/cs5013206
[19]
R. V. Ottenbacher, D. G. Samsonenko, E. P. Talsi, K. P. Bryliakov, ACS Catal., 2016, 6: 979-988. DOI:10.1021/acscatal.5b02299
[20]
A. M. Zima, O. Y. Lyakin, R. V. Ottenbacher, K. P. Bryliakov, E. P. Talsi, ACS Catal., 2016, 6: 5399-5404. DOI:10.1021/acscatal.6b01473
[21]
W. Dai, J. Li, B. Chen, G. Li, Y. Lv, L. Wang, S. Gao, Org. Lett., 2013, 15: 5658-5661. DOI:10.1021/ol402612x
[22]
W. Dai, J. Li, G. Li, H. Yang, L. Wang, S. Gao, Org. Lett., 2013, 15: 4138-4141. DOI:10.1021/ol401812h
[23]
M. Wu, B. Wang, S. F. Wang, C. G. Xia, W. Sun, Org. Lett., 2009, 11: 3622-3625. DOI:10.1021/ol901400m
[24]
M. Wu, C. X. Miao, S. F. Wang, X. X. Hu, C. G. Xia, F. E. Kühn, W. Sun, Adv. Synth. Catal., 2011, 353: 3014-3022. DOI:10.1002/adsc.v353.16
[25]
C. X. Miao, B. Wang, Y. Yong, C. G. Xia, Y. M. Lee, W. W. Nam, W. Sun, J. Am. Chem. Soc., 2016, 138: 936-943. DOI:10.1021/jacs.5b11579
[26]
D. Y. Shen, B. Qiu, D. Q. Xu, C. X. Miao, C. G. Xia, W. Sun, Org. Lett., 2016, 18: 372-375. DOI:10.1021/acs.orglett.5b03309
[27]
C. X. Miao, X. B. Yan, D. Q. Xu, C. G. Xia, W. Sun, Adv. Synth. Catal., 2017, 359: 476-484. DOI:10.1002/adsc.201600848
[28]
B. Wang, C. X. Miao, S. F. Wang, F. E. Kühn, C. G. Xia, W. Sun, J. Organomet. Chem., 2012, 715: 9-12. DOI:10.1016/j.jorganchem.2012.03.034
[29]
B. Wang, C. X. Miao, S. F. Wang, C. G. Xia, W. Sun, Chem. Eur. J., 2012, 18: 6750-6753. DOI:10.1002/chem.201103802
[30]
B. Wang, S. F. Wang, C. G. Xia, W. Sun, Chem. Eur. J., 2012, 18: 7332-7335. DOI:10.1002/chem.201200992
[31]
D. Y. Shen, C. X. Miao, S. F. Wang, C. G. Xia, W. Sun, Eur. J. Inorg. Chem., 2014, 2014: 5777-5782.
[32]
B. Qiu, D. Q. Xu, Q. S. Sun, C. X. Miao, Y. M. Lee, X. X. Li, W. Nam, W. Sun, ACS Catal., 2018, 8: 2479-2487. DOI:10.1021/acscatal.7b03601
[33]
Q. Zhu, H. Shen, Z. Yang, H. Ji, Chin. J. Catal., 2016, 37: 1227-1234. DOI:10.1016/S1872-2067(15)61122-6
[34]
I. Prat, A. Company, T. Corona, T. Parella, X. Ribas, M. Costas, Inorg. Chem., 2013, 52: 9229-9244. DOI:10.1021/ic4004033
[35]
W. N. Oloo, K. K. Meier, Y. Wang, S. Shaik, E. Münck, L. Que, Nat. Commun., 2014, 5: 3046. DOI:10.1038/ncomms4046
[36]
F. Wang, W. Sun, C. Xia, Y. Wang, J. Biol. Inorg. Chem., 2017, 22: 987-998. DOI:10.1007/s00775-017-1477-9
[37]
J. Y. Du, C. X. Miao, C. G. Xia, Y. M. Lee, W. Nam, W. Sun, ACS Catal., 2018, 8: 4528-4538. DOI:10.1021/acscatal.8b00874